Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002584065 | SCV002940571 | benign | Ectodermal dysplasia and immunodeficiency 2 | 2022-11-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002584064 | SCV003563481 | uncertain significance | Inborn genetic diseases | 2021-07-20 | criteria provided, single submitter | clinical testing | The c.532G>A (p.A178T) alteration is located in exon 3 (coding exon 3) of the NFKBIA gene. This alteration results from a G to A substitution at nucleotide position 532, causing the alanine (A) at amino acid position 178 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |